| Phase 3 |
| NCT03937635 |
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With… |
Smoldering Plasma Cell Myeloma |
Recruiting |
| NCT04423211 |
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… |
Biochemically Recurrent Prostate Carcinoma |
Recruiting |
| NCT04566328 |
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple… |
Plasma Cell Myeloma |
Recruiting |
| NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of… |
Metastatic Colorectal Carcinoma |
Recruiting |
| NCT06475989 |
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer |
Refractory Differentiated Thyroid Gland Carcinoma |
Recruiting |
| NCT01863550 |
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With… |
Plasma Cell Myeloma |
Active, Not Recruiting |
| NCT02201992 |
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has… |
ALK Gene Rearrangement |
Active, Not Recruiting |
| NCT00003641 |
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma |
Melanoma (Skin) |
Active, Not Recruiting |
| NCT03233191 |
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for… |
Breast Screening |
Active, Not Recruiting |
| NCT04248452 |
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients… |
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 |
Active, Not Recruiting |
| NCT05721755 |
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous… |
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
Active, Not Recruiting |
| NCT03267433 |
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual… |
Mantle Cell Lymphoma |
Active, Not Recruiting |
| NCT05538663 |
Intravesical BCG vs GEMDOCE in NMIBC |
Non-muscle-invasive Bladder Cancer |
Active, Not Recruiting |
| NCT05863351 |
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited… |
Metastatic Renal Cell Carcinoma |
Active, Not Recruiting |
| NCT02445391 |
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following… |
Estrogen Receptor Negative |
Active, Not Recruiting |
| NCT04484818 |
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy… |
Prostate Carcinoma |
Active, Not Recruiting |
| Phase 2/3 |
| NCT07001748 |
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With… |
Gastric Adenocarcinoma |
Recruiting |
| NCT04559139 |
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the… |
Stage II Gallbladder Cancer AJCC v8 |
Active, Not Recruiting |
| NCT07765433 |
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the… |
Locally Advanced Biliary Tract Adenocarcinoma |
Not Yet Recruiting |
| Phase 2 |
| NCT03493425 |
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone… |
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 |
Recruiting |
| NCT02734537 |
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06319027 |
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain… |
Glioblastoma, IDH-Wildtype |
Recruiting |
| NCT01824875 |
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic… |
Gastrinoma |
Active, Not Recruiting |
| NCT01898494 |
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without… |
Human Papilloma Virus Infection |
Active, Not Recruiting |
| NCT05710328 |
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for… |
Anatomic Stage II Breast Cancer AJCC v8 |
Active, Not Recruiting |